Open original FDA record ↗Recall record
- FDA identifier
- Z-0824-2012
- Company in FDA record
- Hemo Cue, Inc.
- FDA classification date
- Jan 20, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
A recall was initiated because Hemocue confirmed that the package insert for Hemocue Glucose 201 Microcuvettes had errors in two sections.
Source facts
- Action
- HemoCue sent a Medical Device Correction Notification letter dated June 14, 2011, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Customers were instructed to passed on the notice to all that need to be aware with their organization or to any organization where the affected lot numbers have been distributed. Customers were instructed to sign the Correction Notification Verification form below and return to HemoCue Inc. Customers received the revised package insert with the notification letter. Customers with any questions regarding the Correction Notification could please call (562) 668-5665.
- Initiated
- 2011-05-30
- Root cause
- Packaging process control
- Terminated
- 2012-03-02
- Distribution
- Worldwide Distribution--USA (nationwide) and the countries of Czech Republic, Denmark, Slovenia, Norway, Sweden, Switzerland, United Kingdom, Finland, Germany, Netherlands, Poland, Romania, and Tanzania.
- Recall number
- Z-0824-2012
- Recall status
- Terminated
- CDRH record ID
- 105712
- FDA classified
- 2012-01-20
- Recall event number
- 60539